A Year To Remember For US Drug Launches
A record-breaking 46 novel drugs and biologics were approved by FDA in 2017. The number of drugs that launched were plentiful and several were highly innovative, ushering in a new era of therapeutic breakthroughs. Turning pioneering medicines into commercial successes will be the test.
You may also be interested in...
The view from 2020: Scrip looks back at the most successful commercial launches of the decade.
The number of US drug approvals in 2018 was striking, but most of the novel products launched last year are for rare diseases or niche cancers, meaning commercial success may be in the eye of the beholder.
2017 was the second-best year for new drug launches worldwide since the start of the millennium, new research by Informa Pharma Intelligence's Pharmaprojects has found.